GATHER2 | Geographic Atrophy Therapy Trial

This Website Uses Cookies

Information about Cookies
This site uses both necessary and analytical cookies. Necessary cookies help make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies. Analytical cookies allow us to collect information about visitors to the website, which pages they visited, how long they visited, and where they navigated to next. This website uses a limited number of analytical cookies to help us collect information about our visitors in order for us to improve the website and its content. We do not seek to collect or process personal information of our website visitors, such as IP addresses or geolocation data beyond the level of the US state from which a visitor accessed our website.

To learn more about cookies, please see our Privacy Policy.

This website uses cookies for analytics and to improve website functioning and content. This site uses necessary and analytical cookies.

Healthcare Provider Login
Contact Us

Contact Us
Thank you for your interest in the GATHER2 clinical trial. At this time, enrollment for the GATHER2 clinical trial is closed.
Accessibility Options

Accessibility Options

Text Size

Turn Motion Off

Color Themes

Contact Us
For more information, contact IVERIC bio by phone: 1-833-ZIMURA2 (1-833-946-8722) toll-free at any time. A representative will take your call between 9:00 AM and 5:00 PM Eastern Time, Monday through Friday.
If you call after hours or during the weekend, please leave a message and we will attempt to return your call by the next business day.
Accessibility Options

Text Size

Color Themes

Home
About GATHER2
Clinical Trial
About GATHER2
Participation Requirements
Locations
COVID-19 Precautions
About Clinical Trials
About GA Associated
with AMD
Resources &
Support
Resources
Video Testimonials
Doctor Discussion Guide
FAQs
Healthcare Provider Login

Locations

Find a GATHER2 Clinical Trial Location Near You

GATHER2 has clinical trial locations throughout the United States and Canada.

Thank you for your interest in the GATHER2 clinical trial. At this time, enrollment for the GATHER2 clinical trial is closed.

United States :
- California :
  - Beverly Hills
  - Campbell
  - Fresno
  - Fullerton
  - Irvine
  - La Jolla
  - Los Angeles
  - Mountain View
  - Oxnard
  - Palm Desert
  - Palo Alto
  - Pasadena
  - Redlands
  - Sacramento
  - Santa Ana
- Colorado :
  - Aurora
  - Colorado Springs
  - Golden
- Connecticut:
  - Danbury
  - Waterford
- Florida :
  - Altamonte Springs
  - Deerfield Beach
  - Fort Myers
  - Ft. Lauderdale
  - Gainesville
  - Melbourne
  - Miami
  - Palm Beach Gardens
  - Pensacola
  - Sarasota
  - St. Petersburg
  - Stuart
  - Tallahassee
  - Tampa
  - Winter Haven
- Georgia :
  - Atlanta
  - Augusta
  - Marietta
- Hawaii :
  - Aiea
- Iowa :
  - West Des Moines
- Illinois :
  - Lemont
  - Peoria
- Indiana :
  - Indianapolis
- Kansas :
  - Shawnee Mission
  - Wichita
- Louisiana :
  - New Orleans
- Massachusetts:
  - Boston
  - Peabody
  - Springfield
  - Worcester
- Maryland :
  - Baltimore
  - Chevy Chase
  - Hagerstown
- Michigan :
  - Royal Oak
- Minnesota :
  - Minneapolis
- Missouri :
  - St. Louis
- New Jersey :
  - Bloomfield
  - Lawrenceville
- New Mexico :
  - Albuquerque
- Nevada :
  - Henderson
  - Reno
- New York :
  - Great Neck
  - Hauppauge
  - Liverpool
  - New York
  - Oceanside
  - Rochester
  - Slingerlands
  - Troy
- North Carolina :
  - Asheville
- Ohio :
  - Cincinnati
  - Columbus
- Oregon :
  - Ashland
  - Portland
- Pennsylvania:
  - Philadelphia
  - West Mifflin
- South Carolina:
  - Beaufort
  - Ladson
  - Mount Pleasant
  - West Columbia
- South Dakota:
  - Rapid City
- Tennessee :
  - Johnson City
  - Knoxville
- Texas :
  - Abilene
  - Amarillo
  - Austin
  - Dallas
  - Houston
  - McAllen
  - San Antonio
  - Southlake
  - Temple
  - The Woodlands
  - Willow Park
- Utah :
  - Salt Lake City
- Virginia :
  - Norfolk
  - Richmond
  - Roanoke
- Washington :
  - Bellevue
  - Silverdale
Canada :
- Alberta :
  - Calgary
- British Columbia :
  - Vancouver
- Ontario :
  - London
  - Mississauga
  - Ottawa
  - Toronto
- Quebec :
  - Montreal

Download our Doctor Discussion Guide and start a conversation with your eye doctor about participating in GATHER2.

Thank you for your interest in the GATHER2 clinical trial. At this time, enrollment for the GATHER2 clinical trial is closed.

ZIMURA^® IS AN INVESTIGATIONAL PRODUCT AND HAS NOT BEEN APPROVED BY THE FDA. SAFETY AND EFFICACY OF ZIMURA^® FOR AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY HAVE NOT BEEN ESTABLISHED. PLEASE SPEAK TO YOUR DOCTOR ABOUT PARTICIPATING IN THIS TRIAL.

Zimura^® (avacincaptad pegol) is a registered trademark of IVERIC bio, Inc.